Yanagida S - Search Results

1

FTY720 Inhibits Expansion of Breast Cancer Stem Cells via PP2A Activation.

Hirata N, Yamada S, Yanagida S, Ono A, Kanda Y. Hirata N, et al. Among authors: yanagida s. Int J Mol Sci. 2021 Jul 6;22(14):7259. doi: 10.3390/ijms22147259. Int J Mol Sci. 2021. PMID: 34298877 Free PMC article.

2

Comprehensive Cardiotoxicity Assessment of COVID-19 Treatments Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Yanagida S, Satsuka A, Hayashi S, Ono A, Kanda Y. Yanagida S, et al. Toxicol Sci. 2021 Aug 30;183(1):227-239. doi: 10.1093/toxsci/kfab079. Toxicol Sci. 2021. PMID: 34142159

3

Chronic cardiotoxicity assessment of BMS-986094, a guanosine nucleotide analogue, using human iPS cell-derived cardiomyocytes.

Yanagida S, Satsuka A, Hayashi S, Ono A, Kanda Y. Yanagida S, et al. J Toxicol Sci. 2021;46(8):359-369. doi: 10.2131/jts.46.359. J Toxicol Sci. 2021. PMID: 34334557 Free article.

4

Lysophosphatidic Acid Promotes the Expansion of Cancer Stem Cells via TRPC3 Channels in Triple-Negative Breast Cancer.

Hirata N, Yamada S, Yanagida S, Ono A, Yasuhiko Y, Nishida M, Kanda Y. Hirata N, et al. Among authors: yanagida s. Int J Mol Sci. 2022 Feb 10;23(4):1967. doi: 10.3390/ijms23041967. Int J Mol Sci. 2022. PMID: 35216080 Free PMC article.

5

Transforming Growth Factor Beta Promotes the Expansion of Cancer Stem Cells via S1PR3 by Ligand-Independent Notch Activation.

Hirata N, Yamada S, Yanagida S, Ono A, Yasuhiko Y, Kanda Y. Hirata N, et al. Among authors: yanagida s. Biol Pharm Bull. 2022;45(5):649-658. doi: 10.1248/bpb.b22-00112. Biol Pharm Bull. 2022. PMID: 35491169 Free article.

6

SARS-CoV-2 induces barrier damage and inflammatory responses in the human iPSC-derived intestinal epithelium.

Yamada S, Noda T, Okabe K, Yanagida S, Nishida M, Kanda Y. Yamada S, et al. Among authors: yanagida s. J Pharmacol Sci. 2022 Jul;149(3):139-146. doi: 10.1016/j.jphs.2022.04.010. Epub 2022 May 2. J Pharmacol Sci. 2022. PMID: 35641026 Free PMC article. Review.

7

Proarrhythmia Risk Assessment Using Electro-Mechanical Window in Human iPS Cell-Derived Cardiomyocytes.

Yanagida S, Satsuka A, Hayashi S, Ono A, Kanda Y. Yanagida S, et al. Biol Pharm Bull. 2022;45(7):940-947. doi: 10.1248/bpb.b22-00268. Biol Pharm Bull. 2022. PMID: 35786601 Free article.

8

Contractility assessment of human iPSC-derived cardiomyocytes by using a motion vector system and measuring cell impedance.

Satsuka A, Hayashi S, Yanagida S, Ono A, Kanda Y. Satsuka A, et al. Among authors: yanagida s. J Pharmacol Toxicol Methods. 2022 Nov-Dec;118:107227. doi: 10.1016/j.vascn.2022.107227. Epub 2022 Oct 13. J Pharmacol Toxicol Methods. 2022. PMID: 36243255

9

Activation of the urotensin-II receptor by remdesivir induces cardiomyocyte dysfunction.

Ogawa A, Ohira S, Kato Y, Ikuta T, Yanagida S, Mi X, Ishii Y, Kanda Y, Nishida M, Inoue A, Wei FY. Ogawa A, et al. Among authors: yanagida s. Commun Biol. 2023 May 12;6(1):511. doi: 10.1038/s42003-023-04888-x. Commun Biol. 2023. PMID: 37173432 Free PMC article.

10

An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models.

Urano E, Itoh Y, Suzuki T, Sasaki T, Kishikawa JI, Akamatsu K, Higuchi Y, Sakai Y, Okamura T, Mitoma S, Sugihara F, Takada A, Kimura M, Nakao S, Hirose M, Sasaki T, Koketsu R, Tsuji S, Yanagida S, Shioda T, Hara E, Matoba S, Matsuura Y, Kanda Y, Arase H, Okada M, Takagi J, Kato T, Hoshino A, Yasutomi Y, Saito A, Okamoto T. Urano E, et al. Among authors: yanagida s. Sci Transl Med. 2023 Aug 30;15(711):eadi2623. doi: 10.1126/scitranslmed.adi2623. Epub 2023 Aug 30. Sci Transl Med. 2023. PMID: 37647387

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters